Skip to main content

Table 1 Patient characteristics (cohort II and CD*)

From: Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56dim natural killer cells

Characteristic

Value

Patients with GPA, n

22

Men/women, n

14/8

GPA in remission, n (%)

12/22 (55 %)

 Age in years, median (range)

55.5 (35–79)

 Duration of remission in years  (of inactive GPA), mean (range)

4.4 (1–20)

GPA non remission (active), n (%)

10/22 (45 %)

 Age in years, median (range)

51.5 (33–64)

 BVAS, mean (range)

4.5 (0–19)

Localized GPA (upper airways and ENT organs only), n (%)

4/22 (18 %)

Generalized GPA, n (%)

18/22 (82 %)

ANCA

 

 Positive

17/22 (77 %)

 Negative

3/22 (14 %)

 Not determinable

2/28 (9 %)

Patients with CD, n

12

Men/women, n

3/9

  1. GPA granulomatosis with polyangiitis, BVAS Birmingham vasculitis activity score, ENT ear, nose and throat, ANCA antineutrophil cytoplasmic antibody, CD* inactive systemic inflammatory control diseases other than GPA comprising systemic lupus erythematosus (n = 4), panarteriitis nodosa (n = 1), overlap connective tissue disease (n = 1), chronic inflammatory bowel disease (n = 1), CREST syndrome (n = 1), primary Sjögren’s syndrome (n = 1), polymyalgia rheumatica (n = 1) and giant cell arteriitis (n = 2)